Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dentiva
- Development stage
- Unknown
- Lead developer
- Nuvora
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Dentiva is an over-the-counter (OTC) oral lozenge developed by Nuvora, Inc., designed to maintain oral hygiene and provide long-lasting fresh breath. Utilizing a patented sustained-release technology (SuRe®), the lozenge slowly releases a triple-action formulation over several hours. Key active components include xylitol and essential oils (peppermint, eucalyptus, thymol) to combat plaque-forming bacteria, sodium bicarbonate to neutralize oral pH and prevent acid erosion of tooth enamel, and zinc gluconate to capture and eliminate volatile sulfur compounds (VSCs) responsible for halitosis. It also contains calcium to support enamel remineralization and maintain mineral balance in the oral cavity.
- Brand names
- Dentiva
Beyond the preview
Go deeper on Dentiva.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dentiva.